These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 19533803)

  • 1. Drug-induced liver injury: is it somehow foreseeable?
    Tarantino G; Di Minno MN; Capone D
    World J Gastroenterol; 2009 Jun; 15(23):2817-33. PubMed ID: 19533803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily sesame oil supplementation mitigates ketoconazole-induced oxidative stress-mediated apoptosis and hepatic injury.
    Periasamy S; Liu CT; Chien SP; Chen YC; Liu MY
    J Nutr Biochem; 2016 Nov; 37():67-75. PubMed ID: 27619544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese herbal medicine induced liver injury].
    Gao XD; Fan YH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):478-80. PubMed ID: 19567037
    [No Abstract]   [Full Text] [Related]  

  • 4. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology.
    Prandota J
    Am J Ther; 2005; 12(3):254-61. PubMed ID: 15891270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug- and toxin-induced hepatotoxicity].
    Grünhage F; Fischer HP; Sauerbruch T; Reichel C
    Z Gastroenterol; 2003 Jun; 41(6):565-78. PubMed ID: 12806543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.
    Xuan J; Chen S; Ning B; Tolleson WH; Guo L
    Chem Biol Interact; 2016 Aug; 255():63-73. PubMed ID: 26477383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model.
    Weber LW; Boll M; Stampfl A
    Crit Rev Toxicol; 2003; 33(2):105-36. PubMed ID: 12708612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
    Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
    Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective effects of ascorbic acid, cimetidine, and nifedipine on diethyldithiocarbamate-induced hepatic toxicity in albino rats.
    Gaafa KM; Badawy MM; Hamza AA
    Drug Chem Toxicol; 2011 Oct; 34(4):405-19. PubMed ID: 21770724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and related human risk factors for hepatic damage by usnic acid containing nutritional supplements.
    Foti RS; Dickmann LJ; Davis JA; Greene RJ; Hill JJ; Howard ML; Pearson JT; Rock DA; Tay JC; Wahlstrom JL; Slatter JG
    Xenobiotica; 2008 Mar; 38(3):264-80. PubMed ID: 18274956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiosyncratic drug-induced liver injury: an overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2007 Nov; 6(6):673-84. PubMed ID: 17967156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central role of mitochondria in drug-induced liver injury.
    Pessayre D; Fromenty B; Berson A; Robin MA; Lettéron P; Moreau R; Mansouri A
    Drug Metab Rev; 2012 Feb; 44(1):34-87. PubMed ID: 21892896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-induced and toxic liver diseases].
    Hütteroth TH
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S226-8. PubMed ID: 16435719
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
    Utkarsh D; Loretz C; Li AP
    Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of hepatotoxic drug (benzbromarone) induced mitochondrial membrane permeability transition.
    Shirakawa M; Sekine S; Tanaka A; Horie T; Ito K
    Toxicol Appl Pharmacol; 2015 Oct; 288(1):12-8. PubMed ID: 26148448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanospheres as a technological alternative to suppress hepatic cellular damage and impaired bioenergetics caused by nerolidol in Nile tilapia (Oreochromis niloticus).
    Baldissera MD; Souza CF; Velho MC; Bassotto VA; Ourique AF; Da Silva AS; Baldisserotto B
    Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):751-759. PubMed ID: 31953674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin induced hepatic oxidative stress and apoptotic damage via MAPKs, mitochondria, calpain and caspase12 dependent pathways.
    Pal S; Ghosh M; Ghosh S; Bhattacharyya S; Sil PC
    Food Chem Toxicol; 2015 Sep; 83():36-47. PubMed ID: 26051349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea extract and the risk of drug-induced liver injury.
    Teschke R; Zhang L; Melzer L; Schulze J; Eickhoff A
    Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1663-76. PubMed ID: 25316200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of citral on mouse hepatic cytochrome P450 enzymes.
    Tang H; Long N; Dai M; Lin L; Li J; Sun F; Guo L
    Pharm Biol; 2018 Dec; 56(1):337-343. PubMed ID: 29969356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Sakatis MZ; Reese MJ; Harrell AW; Taylor MA; Baines IA; Chen L; Bloomer JC; Yang EY; Ellens HM; Ambroso JL; Lovatt CA; Ayrton AD; Clarke SE
    Chem Res Toxicol; 2012 Oct; 25(10):2067-82. PubMed ID: 22931300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.